Skip to main content

Identification of mutations by ultra-deep sequencing may help predict nilotinib response in CML-CP patients

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Identification of mutations by ultra-deep sequencing may help predict nilotinib response in CML-CP patients

User login

Username

Password

Reset your password

Type	Lead	score